Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting, 47658 [2014-19218]
Download as PDF
47658
Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices
HRSA, Room 11C–26, 5600 Fishers Lane,
Rockville, MD 20857; telephone (301) 443–
6634 or email: aherzog@hrsa.gov.
Dated: August 6, 2014.
Jackie Painter,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–19201 Filed 8–13–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Council on Blood Stem Cell
Transplantation; Notice of Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Council on Blood Stem
Cell Transplantation.
Date and Time: September 15, 2014, 8:00
a.m. to 4:30 p.m. (Eastern Standard Time).
Place: Fishers Lane Conference Center,
Terrace Level, 5635 Fishers Lane, Rockville,
MD 20852.
Status: The meeting will be open to the
public.
Purpose: Pursuant to Public Law 109–129,
42 U.S.C. 274k (section 379 of the Public
Health Service Act, as amended), the
Advisory Council on Blood Stem Cell
Transplantation (ACBSCT) advises the
Secretary of the Department of Health and
Human Services and the Administrator,
Health Resources and Services
Administration, on matters related to the
activities of the C.W. Bill Young Cell
Transplantation Program (Program) and the
National Cord Blood Inventory Program.
Agenda: The Council will hear reports
from ACBSCT Work Groups including:
Realizing the Potential of Cord Blood; Access
to Transplantation; and Advancing
Hematopoietic Stem Cell Transplantation for
Hemoglobinopathies. The Council also will
hear presentations and discussions on topics
including: Financial Issues Related to Stem
Cell Transplantation and Quality of Care.
Agenda items are subject to changes as
priorities indicate.
After Council discussions, members of the
public will have an opportunity to provide
comments. Because of the Council’s full
agenda and the time frame in which to cover
the agenda topics, public comment will be
limited. All public comments will be
included in the record of the ACBSCT
meeting. Meeting summary notes will be
posted on the HRSA’s Program Web site at
https://bloodcell.transplant.hrsa.gov/ABOUT/
Advisory_Council/.
Those participating in this meeting can
register and view the draft meeting agenda by
visiting https://www.blsmeetings.net/acbsct.
The deadline to register for this meeting is
Friday, September 12, 2014. For all logistical
questions and concerns, please contact Anita
Allen, Seamon Corporation, by calling (301)
VerDate Mar<15>2010
17:56 Aug 13, 2014
Jkt 232001
658–3442 or by sending an email to aallen@
seamoncorporation.com.
Public Comment: It is preferred that
persons interested in providing an oral
presentation submit a written request, along
with a copy of their presentation to: Patricia
Stroup, MBA, MPA, Executive Secretary,
Healthcare Systems Bureau, Health
Resources and Services Administration,
Room 17W65, 5600 Fishers Lane, Rockville,
Maryland 20857 or email at pstroup@
hrsa.gov. Requests should contain the name,
address, telephone number, email address,
and any business or professional affiliation of
the person desiring to make an oral
presentation. Groups having similar interests
are requested to combine their comments and
present them through a single representative.
The allocation of time may be adjusted to
accommodate the level of expressed interest.
Persons who do not file an advance request
for a presentation, but desire to make an oral
statement, may request this at the time of the
public comment period. Public participation
and ability to comment will be limited to
time as it permits.
For Further Information Contact:
Patricia Stroup, MBA, MPA, Executive
Secretary, Healthcare Systems Bureau, Health
Resources and Services Administration, 5600
Fishers Lane, Room 17W63, Rockville,
Maryland 20857; telephone (301) 443–1127.
Dated: August 8, 2014.
Jackie Painter,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–19218 Filed 8–13–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Centers for Disease Control and
Prevention (CDC)/Health Resources
and Services Administration (HRSA)
Advisory Committee on HIV, Viral
Hepatitis, and Sexually Transmitted
Disease (STD) Prevention and
Treatment
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
The Health Resources and
Services Administration (HRSA) is
requesting nominations to fill three
vacancies on the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment
(CHACHSPT).
DATES: Nominations should be
submitted electronically or in writing,
and must be postmarked by August 30,
2014.
ADDRESSES: All nominations should be
submitted by email to: Shelley B.
Gordon, Public Health Analyst, at
SUMMARY:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
sgordon@hrsa.gov or mailed to Shelley
B. Gordon, HIV/AIDS Bureau, HRSA,
5600 Fishers Lane, Room 7C–26,
Rockville, Maryland 20857, no later
than September 15, 2014.
FOR FURTHER INFORMATION CONTACT:
Shelley B. Gordon, Public Health
Analyst, HIV/AIDS Bureau, HRSA, 5600
Fishers Lane, Room 7C–26, Rockville,
Maryland 20857, sgordon@hrsa.gov,
301–443–9684.
SUPPLEMENTARY INFORMATION: The
CHACHSPT is governed by the Federal
Advisory Committee Act, Public Law
92–643 (5 U.S.C. App. 2), as amended,
which sets forth the standards for the
formation and use of advisory
committees. The CHACHSPT consists of
18 experts knowledgeable in the fields
of public health, epidemiology,
laboratory practices, immunology,
infectious diseases, drug abuse,
behavioral science, health education,
healthcare delivery, state health
programs, clinical care, preventive
health, medical education, health
services and clinical research, and
healthcare financing, who are selected
by the Secretary of the U.S. Department
of Health and Human Services (HHS).
The CHACHSPT provides advice to the
Secretary, HHS; the Director, CDC; and
the Administrator, HRSA, on objectives,
strategies, policies, and priorities for
HIV, viral hepatitis, and STD prevention
and treatment efforts including
surveillance of HIV infection, AIDS,
viral hepatitis, other STDs, and related
behaviors; epidemiologic, behavioral,
health services, and laboratory research
on HIV/AIDS, viral hepatitis, and other
STDs; identification of policy issues
related to HIV/viral hepatitis/STD
professional education, patient
healthcare delivery, and prevention
services; agency policies about
prevention of HIV/AIDS, viral hepatitis,
and other STDs, treatment, healthcare
delivery, and research and training;
strategic issues influencing the ability of
CDC and HRSA to fulfill their missions
of providing prevention and treatment
services; programmatic efforts to
prevent and treat HIV, viral hepatitis,
and other STDs; and support to the
agencies in their development of
responses to emerging health needs
related to HIV, viral hepatitis, and other
STDs.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the Committee’s objectives.
Nominees will be selected from
experts having experience in HIV/AIDS,
viral hepatitis, and STDs prevention and
control. Experts in the disciplines of
epidemiology, laboratory practice,
E:\FR\FM\14AUN1.SGM
14AUN1
Agencies
[Federal Register Volume 79, Number 157 (Thursday, August 14, 2014)]
[Notices]
[Page 47658]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-19218]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Council on Blood Stem Cell Transplantation; Notice of
Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Council on Blood Stem Cell Transplantation.
Date and Time: September 15, 2014, 8:00 a.m. to 4:30 p.m.
(Eastern Standard Time).
Place: Fishers Lane Conference Center, Terrace Level, 5635
Fishers Lane, Rockville, MD 20852.
Status: The meeting will be open to the public.
Purpose: Pursuant to Public Law 109-129, 42 U.S.C. 274k (section
379 of the Public Health Service Act, as amended), the Advisory
Council on Blood Stem Cell Transplantation (ACBSCT) advises the
Secretary of the Department of Health and Human Services and the
Administrator, Health Resources and Services Administration, on
matters related to the activities of the C.W. Bill Young Cell
Transplantation Program (Program) and the National Cord Blood
Inventory Program.
Agenda: The Council will hear reports from ACBSCT Work Groups
including: Realizing the Potential of Cord Blood; Access to
Transplantation; and Advancing Hematopoietic Stem Cell
Transplantation for Hemoglobinopathies. The Council also will hear
presentations and discussions on topics including: Financial Issues
Related to Stem Cell Transplantation and Quality of Care. Agenda
items are subject to changes as priorities indicate.
After Council discussions, members of the public will have an
opportunity to provide comments. Because of the Council's full
agenda and the time frame in which to cover the agenda topics,
public comment will be limited. All public comments will be included
in the record of the ACBSCT meeting. Meeting summary notes will be
posted on the HRSA's Program Web site at https://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/.
Those participating in this meeting can register and view the
draft meeting agenda by visiting https://www.blsmeetings.net/acbsct.
The deadline to register for this meeting is Friday, September 12,
2014. For all logistical questions and concerns, please contact
Anita Allen, Seamon Corporation, by calling (301) 658-3442 or by
sending an email to aallen@seamoncorporation.com.
Public Comment: It is preferred that persons interested in
providing an oral presentation submit a written request, along with
a copy of their presentation to: Patricia Stroup, MBA, MPA,
Executive Secretary, Healthcare Systems Bureau, Health Resources and
Services Administration, Room 17W65, 5600 Fishers Lane, Rockville,
Maryland 20857 or email at pstroup@hrsa.gov. Requests should contain
the name, address, telephone number, email address, and any business
or professional affiliation of the person desiring to make an oral
presentation. Groups having similar interests are requested to
combine their comments and present them through a single
representative.
The allocation of time may be adjusted to accommodate the level
of expressed interest. Persons who do not file an advance request
for a presentation, but desire to make an oral statement, may
request this at the time of the public comment period. Public
participation and ability to comment will be limited to time as it
permits.
For Further Information Contact:
Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare
Systems Bureau, Health Resources and Services Administration, 5600
Fishers Lane, Room 17W63, Rockville, Maryland 20857; telephone (301)
443-1127.
Dated: August 8, 2014.
Jackie Painter,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2014-19218 Filed 8-13-14; 8:45 am]
BILLING CODE 4165-15-P